Total Payments
$2,510
2024 Payments
$13.42
Companies
25
Transactions
173
Medicare Patients
1,564
Medicare Billing
$245,173
Payment Breakdown by Category
Food & Beverage$2,510 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,510 | 173 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $846.10 | 77 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $297.13 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $264.68 | 17 | $0 (2019) |
| Abbott Laboratories | $144.22 | 1 | $0 (2019) |
| Lilly USA, LLC | $126.30 | 9 | $0 (2022) |
| Synergy Pharmaceuticals Inc | $99.88 | 2 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $98.75 | 1 | $0 (2019) |
| Edwards Lifesciences Corporation | $80.18 | 1 | $0 (2018) |
| PFIZER INC. | $77.42 | 6 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $63.52 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.42 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($13.42) |
| 2023 | $13.75 | 1 | PFIZER INC. ($13.75) |
| 2022 | $150.58 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($56.51) |
| 2021 | $344.81 | 29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($127.68) |
| 2020 | $116.75 | 9 | Novo Nordisk Inc ($65.41) |
| 2019 | $514.52 | 27 | Abbott Laboratories ($144.22) |
| 2018 | $551.72 | 37 | Novo Nordisk Inc ($168.70) |
| 2017 | $804.74 | 59 | Novo Nordisk Inc ($331.21) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Gastroenterology | ||||||
| 01/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Gastroenterology | ||||||
| 11/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 07/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
| 07/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Gastroenterology | ||||||
| 07/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Gastroenterology | ||||||
| 05/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 04/06/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/24/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 03/14/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 01/27/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Diabetes | ||||||
| 12/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Gastroenterology | ||||||
| 12/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Gastroenterology | ||||||
| 12/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Gastroenterology | ||||||
| 12/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 11/18/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Gastroenterology | ||||||
| 11/18/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Gastroenterology | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Gastroenterology | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Gastroenterology | ||||||
| 09/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Gastroenterology | ||||||
| 09/24/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Neuroscience | ||||||
| 09/09/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Gastroenterology | ||||||
| 08/26/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 08/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 197 | 202 | $59,955 | $23,932 |
| 2022 | 4 | 280 | 288 | $109,719 | $40,722 |
| 2021 | 6 | 461 | 731 | $153,636 | $72,270 |
| 2020 | 7 | 626 | 1,520 | $210,248 | $108,248 |
Total Patients
1,564
Total Services
2,741
Medicare Billing
$245,173
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 91 | $32,760 | $12,206 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 111 | $27,195 | $11,726 | 43.1% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 154 | 159 | $60,814 | $21,568 | 35.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 96 | 99 | $40,788 | $16,079 | 39.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,939 | $1,622 | 41.2% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,178 | $1,454 | 34.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 151 | 158 | $58,396 | $26,972 | 46.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 87 | 302 | $36,240 | $18,444 | 50.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 89 | 90 | $35,730 | $13,819 | 38.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 82 | 94 | $11,750 | $5,805 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 60 | $7,200 | $4,166 | 57.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 27 | $4,320 | $3,064 | 70.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 233 | 986 | $118,320 | $57,857 | 48.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 127 | 155 | $42,488 | $25,505 | 60.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 184 | 244 | $30,500 | $14,547 | 47.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 73 | $8,760 | $4,191 | 47.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 33 | $5,280 | $2,929 | 55.5% |
| 99235 | Hospital observation or inpatient care moderate severity, 50 minutes per day' | Facility | 2020 | 14 | 14 | $2,800 | $1,925 | 68.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 15 | 15 | $2,100 | $1,295 | 61.7% |
About Dr. Michael Kleinman, D.O
Dr. Michael Kleinman, D.O is a Internal Medicine healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740394949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kleinman, D.O has received a total of $2,510 in payments from pharmaceutical and medical device companies, with $13.42 received in 2024. These payments were reported across 173 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,510).
As a Medicare-enrolled provider, Kleinman has provided services to 1,564 Medicare beneficiaries, totaling 2,741 services with total Medicare billing of $245,173. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Marlton, NJ
- Active Since 08/18/2006
- Last Updated 08/18/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740394949
Products in Payments
- Ozempic (Drug) $323.85
- Victoza (Drug) $315.38
- XIFAXAN (Drug) $226.22
- XARELTO (Drug) $209.40
- HeartMate (Device) $144.22
- Saxenda (Drug) $142.85
- Trulance (Drug) $99.88
- LifeVest (Device) $98.75
- RELISTOR ORAL (Drug) $82.22
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $80.18
- TRULICITY (Drug) $75.26
- INVOKANA (Drug) $55.28
- RELISTOR (Drug) $52.21
- ELIQUIS (Drug) $40.73
- EMGALITY (Drug) $38.57
- CHANTIX (Drug) $36.69
- EZALLOR SPRINKLE (Drug) $28.57
- FARXIGA (Drug) $27.00
- (8874) inCourage (Device) $25.45
- Utibron (Drug) $25.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlton
Dr. Beckie Michael, Do, DO
Internal Medicine — Payments: $42,387
Internal Medicine $42,387
Dr. Minhaz Karim, Md, MD
Internal Medicine — Payments: $5,317
Internal Medicine $5,317
Joseph Moran, D.o, D.O
Internal Medicine — Payments: $3,800
Internal Medicine $3,800
Angel Rodis, Md, MD
Internal Medicine — Payments: $2,608
Internal Medicine $2,608
Dr. Brian Jaffe, Md, MD
Internal Medicine — Payments: $2,572
Internal Medicine $2,572
Stuart Gould, M.d, M.D
Internal Medicine — Payments: $2,419
Internal Medicine $2,419